Pearce IP Archives

Most Recent

Drug companies drop bid for ACCC approval of Revlimid patent settlement

Competition & Consumer Protection 2022-07-29 11:44 am By Cat Fredenburgh

Bristol-Myers Squibb unit Celgene and two generic drug makers have withdrawn an application for ACCC approval of a patent settlement that would have allowed for […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

ACCC says agreement to settle Revlimid patent suit could violate cartel laws

Intellectual Property 2022-03-23 2:53 pm By Cat Fredenburgh

The ACCC has refused to authorise a patent settlement and license agreement between Bristol-Myers Squibb unit Celgene and two generic drug makers who sued to […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

After GetSwift, judge could not hear split trial in Revlimid patent case, court told

Intellectual Property 2021-07-20 8:39 pm By Christine Caulfield

A proposal by Bristol-Myers Squibb-owned Celgene to split a second trial into two more hearings in a dispute over patents covering the pharmaceutical maker’s top […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Juno and Bristol-Myers Squibb suffer losses in Revlimid patent war

Intellectual Property 2021-03-25 1:58 pm By Miklos Bolza

A patent battle between Juno Pharmaceuticals and Bristol-Myers Squibb over the blockbuster drug Revlimid has seen both sides suffer early losses, with a judge dismissing […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?